Skip to main content
TipRanks
Go Ultimate75% OFF

Ugro Capital Limited (UGROCAP) AI Stock Analysis

6 Followers
IN:UGROCAP

Ugro Capital Limited

(NSE:UGROCAP)

Select Model
Rating:47Neutral
Price Target:INR 71.00â–¼(-3.51% Downside)
Action:reiterated
Date:11/07/26

Ugro Capital scores below average. The primary drag is financial quality: despite impressive loan book and revenue growth, leverage has risen sharply to 3.55x debt-to-equity, margins have compressed materially, and ROE of ~6% is insufficient to justify the risk taken, with cash flows only just turning positive in FY2026 after years of heavy burn. Compounding this, the technical setup is firmly bearish, with the price well below all key moving averages and negative MACD momentum, though oversold stochastic readings hint at possible near-term stabilization. The main offset is valuation — a P/E under 5 prices in substantial pessimism and offers upside if asset quality holds and profitability improves, but with no dividend, investors are not compensated while waiting. Key factors to watch are asset quality through a full credit cycle, margin stabilization, and sustained positive cash generation.

Positive Factors
Strong Revenue GrowthSustained revenue expansion indicates that UGRO Capital is continuing to build scale in its MSME lending franchise. A larger loan platform can support operating leverage, broaden distribution reach, and strengthen the company’s ability to compound interest and fee income over the next several quarters.
Negative Factors
High Financial LeverageElevated leverage reduces financial flexibility for an MSME lender and increases sensitivity to funding costs, refinancing conditions, and credit losses. The sharp rise from about 0.83x in 2021 means a downturn could place greater pressure on capital resources and constrain future loan-book expansion.

Ugro Capital Limited (UGROCAP) vs. iShares MSCI India ETF (INDA)

-70%-60%-50%-40%-30%-20%-10%0%10%IN:UGROCAP-57.53%INDA-4.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 12.69B
Dividend Yield
―
Average Volume (3M)
60.64K
Price to Earnings (P/E)
5.1
Beta (1Y)
1.23
Revenue Growth
32.85%
EPS Growth
-8.30%
Country
India
Employees
2,095
Sector
General
Sector Strength
55
Industry
Financial - Credit Services

Ugro Capital Limited Business Overview & Revenue Model

Company Description

UGRO Capital Limited functions as a non-banking financial company primarily engaged in offering various lending services. The firm provides business financing specifically targeting diverse sectors such as healthcare, education, chemicals, food proce...

How the Company Makes Money

UGRO Capital primarily makes money through a lending (credit) business model. Its main revenue stream is interest income earned on loans extended to MSME customers: the company borrows funds (e.g., via bank lines, market borrowings, securitisation/as...

Ugro Capital Limited Financial Statement Overview

Summary

Ugro Capital has scaled rapidly, with revenue rising from ₹1.3 billion in FY2021 to ₹14.7 billion in FY2026 and net income reaching ₹1.75 billion, but the quality of that growth is weak. Gross margins have halved (~37% to ~15%), net margins fell from ~21.5% to ~11.9%, and EBIT margins have turned negative, pointing to higher funding costs and operating pressure. Leverage has escalated sharply, with debt-to-equity climbing from 0.83x to 3.55x and total debt reaching ₹103.2 billion, while ROE of ~6% remains well below the cost of equity for a lender carrying this risk profile. Cash flow has been a persistent weak point, deeply negative through FY2025 (-₹24.7 billion), though FY2026 shows an encouraging inflection to positive operating cash flow of ₹2.1 billion. Revenue growth has also decelerated to ~14.6% from 82% in FY2023, signaling a maturing growth phase. Overall: strong scale-up execution offset by margin compression, high leverage, and untested asset quality.

Income Statement

52Neutral

Balance Sheet

38Negative

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue20.59B14.74B9.64B7.07B4.88B2.68B
Gross Profit7.65B2.23B1.29B995.24M678.77M624.11M
EBITDA2.80B-140.04M2.62B2.19B1.07B348.23M
Net Income2.16B1.75B1.44B1.19B397.76M145.51M
Balance Sheet
Total Assets143.46B140.75B91.68B62.80B43.06B28.54B
Cash, Cash Equivalents and Short-Term Investments14.80B18.25B5.53B883.64M2.12B1.60B
Total Debt109.73B108.68B69.04B46.53B31.49B18.31B
Total Liabilities113.17B111.69B71.22B48.42B33.22B18.88B
Stockholders Equity30.29B29.06B20.46B14.38B9.84B9.67B
Cash Flow
Free Cash Flow01.71B-25.00B-15.38B-12.61B-11.46B
Operating Cash Flow02.14B-24.74B-15.35B-12.20B-11.32B
Investing Cash Flow0-19.64B-799.24M-2.30B-845.42M413.80M
Financing Cash Flow027.51B26.55B18.14B12.79B10.23B

Ugro Capital Limited Technical Analysis

Technical Analysis SentimentNeutral
Last Price73.58

Price Trends

50DMA78.09Negative
100DMA85.76Negative
200DMA96.40Negative

Market Momentum

MACD-2.16Negative
RSI49.31Neutral
STOCH80.38Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:UGROCAP, the sentiment is Neutral. The current price of 73.58 is above the 20-day moving average (MA) of 71.89, below the 50-day MA of 78.09, and below the 200-day MA of 96.40, indicating a neutral trend. The MACD of -2.16 indicates Negative momentum. The RSI at 49.31 is Neutral, neither overbought nor oversold. The STOCH value of 80.38 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:UGROCAP.

Ugro Capital Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:UGROCAP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:SBFCIN:SBFC68NeutralINR 96.37B18.76――28.39%28.14%
IN:MASFININ:MASFIN62NeutralINR 47.43B11.37―0.76%22.71%23.45%
IN:PAISALOIN:PAISALO59NeutralINR 69.87B25.42―0.13%23.67%26.77%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:INDOSTARIN:INDOSTAR48NeutralINR 30.22B-7.75――-0.48%-153.07%
IN:UGROCAPIN:UGROCAP47NeutralINR 11.31B5.13――32.85%-8.30%
IN:MUTHOOTMFIN:MUTHOOTMF46NeutralINR 28.96B16.61――15.94%―

* General Sector Average

Performance Comparison

-50%0%50%100%150%IN:UGROCAPIN:INDOSTARIN:MASFININ:MUTHOOTMFIN:PAISALOIN:SBFCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:UGROCAP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:UGROCAPUgro Capital Limited73.58-101.37-57.94%
IN:INDOSTARIndoStar Capital Finance Limited186.95-40.05-17.64%
IN:MASFINMAS Financial Services Ltd.261.40-53.40-16.96%
IN:MUTHOOTMFMuthoot Microfin Ltd169.85-1.55-0.90%
IN:PAISALOPaisalo Digital Ltd.74.3339.76115.03%
IN:SBFCSBFC Finance Limited86.84-20.61-19.18%

Ugro Capital Limited Corporate Events

Ugro Capital Sets Earnings Call to Discuss Q2 and Half-Year FY27 Results

Oct 29, 2026

Ugro Capital Limited has scheduled an earnings conference call on 6 November 2026 at 4:00 p.m. IST to discuss its unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026. The call, compliant with...

Ugro Capital Publishes Hearing Notice for Amalgamation with Profectus Capital

Oct 24, 2026

Ugro Capital Limited, a Mumbai-based non-banking financial company listed on BSE and NSE, operates in India’s credit and financial services market and caters to a wide set of shareholders and creditors. Its governance and disclosure practices are fra...

Ugro Capital to Raise USD 10 Million via Dollar-Denominated Bonds

Oct 9, 2026

Ugro Capital Limited has approved the allotment of up to 1,000 senior, unsecured, rated and listed U.S. dollar-denominated redeemable non-convertible bonds, each with a face value of USD 10,000. The private placement issue, aggregating up to USD 10 m...

UGRO Capital Raises Short-Term Funds via New Commercial Paper Allotment

Sep 9, 2026

UGRO Capital has approved a fresh allotment of commercial papers as part of its routine funding strategy, with the board’s Investment and Borrowing Committee clearing the issuance on 9 September 2026. The commercial papers, carrying a face value of R...

UGRO Capital Sets September Meetings on Profectus Amalgamation

Aug 14, 2026

UGRO Capital has dispatched notices to convene separate meetings of its equity shareholders, secured creditors and unsecured creditors to consider and approve a proposed Scheme of Amalgamation with Profectus Capital Private Limited. The meetings, dir...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026